Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome

Mise à jour : Il y a 4 ans
Référence : NCT00348738

Femme Homme

  • | Pays :
  • Austria
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine whether an increase of blood haemoglobin levels through the substitution of erythropoietin during radiotherapy treatment of cervix cancer patients results in improvement for disease specific survival, tumor response and local control.


Critère d'inclusion

  • Cervix cancer

Liens